project . 2015 - 2021 . Closed

EU-rhythmy

Molecular strategies to treat inherited arrhythmias
Open Access mandate for Publications European Commission
  • Funder: European CommissionProject code: 669387 Call for proposal: ERC-2014-ADG
  • Funded under: H2020 | ERC | ERC-ADG Overall Budget: 2,314,030 EURFunder Contribution: 2,314,030 EUR
  • Status: Closed
  • Start Date
    01 Nov 2015
    End Date
    31 Oct 2021
  • Detailed project information (CORDIS)
  • Open Access mandate
    Research Data: No
Description
Sudden cardiac death (SCD) is a leading cause of death in western countries: coronary artery disease is the major cause of SCD in older subjects while inherited arrhythmogenic diseases are the leading cause of SCD in younger individuals. After 25 years dedicated to research of the molecular bases of heritable arrhythmias, the PI of this proposal now intends to pioneer gene therapy for prevention of SCD: a virtually unexplored field. The development of molecular therapies for rhythm disturbances is a high risk effort however, if successful, it will be highly rewarding. The PI has envisioned an ambitious and comprehensive project to target two severe inherited arr...
Partners
Description
Sudden cardiac death (SCD) is a leading cause of death in western countries: coronary artery disease is the major cause of SCD in older subjects while inherited arrhythmogenic diseases are the leading cause of SCD in younger individuals. After 25 years dedicated to research of the molecular bases of heritable arrhythmias, the PI of this proposal now intends to pioneer gene therapy for prevention of SCD: a virtually unexplored field. The development of molecular therapies for rhythm disturbances is a high risk effort however, if successful, it will be highly rewarding. The PI has envisioned an ambitious and comprehensive project to target two severe inherited arr...
Partners
Any information missing or wrong?Report an Issue